Scientific experts will share their perspectives regarding the unmet needs of PH-HFpEF patients and the relevance of the HELP Study results.
Reducing stressed blood volume with levosimendan
24-hour Levosimendan Infusion Decreases Biventricular Filling Pressures at Rest and Exercise in PH-HFpEF
Helping PH-HFpEF Patients Walk Further with Levosimendan
Levosimendan Improves Hemodynamics and Submaximal Exercise Capacity in PH-HFpEF: Primary Results from the HELP-PH-HFpEFMulticenter Randomized Controlled Trial
© Copyright 2022 Tenax Therapeutics. All Rights Reserved.
Site created by Top Shelf Design